Clinical trial Recruiting at 1 site Interventional Ages 60 and up

WhatsApp-based person-centered self-care support for homebound older adults

Official title: Empowering Homebound Older Adults in Self-care Using a Mobile Health-assisted, Person-centred Care Approach: A Hybrid Effectiveness-implementation Design

Run by The Hong Kong Polytechnic University · NCT06879457 · Data updated 2026-11-12

This project will test whether six bi-weekly WhatsApp video calls with nurse case managers using a person-centered approach help homebound older adults improve self-care, independence, and well-being compared with conventional provider-led calls.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment130 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedMarch 10, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedSeptember 15, 2025
Trial IDNCT06879457 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Cantonese-speaking adults aged 60 or older who leave home no more than twice per week, are moderately frail or less, can use a smartphone, and have sufficient cognition, hearing, and vision to participate.

Probably not a fit

People who are completely bed-bound, cannot hear, see, or communicate effectively, lack a smartphone or stable internet, or cannot use Cantonese are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a hybrid effectiveness-implementation, cluster-randomized controlled trial in Hong Kong enrolling 130 homebound older adults. Participants receive six bi-weekly WhatsApp video-call sessions with nurse case managers over three months, delivered either with a person-centred care (PCC) approach or a conventional provider-led model. Effectiveness outcomes include self-efficacy, functional independence, and psychosocial well-being, while implementation outcomes are measured using the RE-AIM framework. Findings will inform whether digitally delivered, person-centered support can be scaled for aging populations with limited mobility.

Why it matters

Potential benefit: If successful, the program could help homebound older adults maintain or improve functional independence and self-care through a low-cost, scalable digital support model.

How similar studies have gone: Previous telehealth and mHealth interventions for older adults and person-centered care models have shown promising results for self-management and psychosocial outcomes, but randomized evidence specifically for WhatsApp-based support in homebound elders is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 60 years or older;
* Unable to leave home more than twice per week due to physical or functional health problems;
* Own and have basic proficiency in using a smartphone;
* Speak Cantonese;
* Indicate sufficient cognitive ability; and
* Be moderately frail or below.

Exclusion Criteria:

* Unable to hear, see, or communicate effectively;
* Be completely bed-bound; or
* Reside in an area without stable internet coverage.

Where it's running

  • Yan Oi Tong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Prof. Arkers Wong — School of Nursing, The Hong Kong Polytechnic University
  • Study coordinator: Prof. Arkers Wong
  • Email: arkers.wong@polyu.edu.hk
  • Phone: +852 3400 3805

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.